Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Planning your retirement portfolio at 40? Discover essential assets to include for a balanced and secure financial future.
20,742 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
SpaceX has experienced a sharp move after going public, sparking questions about lockups and what it means for future...
You can buy one Costco share for under $1,000 today, a price tag that attracts many new investors. This article expla...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...
A traditional aerospace and defense ETF is delivering double-digit gains this year with no Tesla exposure, challengin...
NVIDIA has slipped about 17% from its May high, leaving investors debating whether the AI powerhouse is finally a bar...
Inflation just 3-year high is reshaping everyday costs and the profit path for credit card lenders. This guide explai...
A rare market moment has many analysts talking about a stock market verge doing something we've never seen before in ...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
As AI and data centers expand, memory demand fuels Micron's growth. This article explains why micron technology: memo...
A cheaper Brazil-focused ETF is outperforming its larger peer in 2026, prompting a rethink of how investors access Br...